RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 58 filers reported holding RAIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,385 | +465.0% | 14,371 | +686.6% | 0.00% | – |
| Q2 2023 | $2,192 | -100.0% | 1,827 | -99.7% | 0.00% | – |
| Q1 2023 | $6,101,726 | +269.1% | 698,138 | +237.8% | 0.00% | – |
| Q4 2022 | $1,653,352 | -10.3% | 206,669 | -45.3% | 0.00% | – |
| Q3 2022 | $1,843,000 | +29.5% | 377,695 | +47.6% | 0.00% | – |
| Q2 2022 | $1,423,000 | -24.0% | 255,887 | -30.7% | 0.00% | – |
| Q1 2022 | $1,873,000 | -80.5% | 369,371 | -50.5% | 0.00% | -100.0% |
| Q4 2021 | $9,614,000 | -19.7% | 746,400 | -6.7% | 0.00% | 0.0% |
| Q3 2021 | $11,968,000 | -3.7% | 800,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $12,432,000 | – | 800,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,571,379 | $7,967,000 | 2.01% |
| Cormorant Asset Management, LP | 2,326,660 | $11,796,000 | 0.91% |
| BVF INC/IL | 3,526,729 | $17,881,000 | 0.72% |
| Boxer Capital, LLC | 1,175,000 | $5,957,000 | 0.31% |
| Perceptive Advisors | 2,483,619 | $12,592,000 | 0.25% |
| Logos Global Management LP | 134,194 | $680,000 | 0.09% |
| Lumina Fund Management LLC | 6,000 | $30,000 | 0.01% |
| Woodline Partners LP | 119,700 | $607,000 | 0.01% |
| Trexquant Investment LP | 28,373 | $144,000 | 0.01% |
| Alyeska Investment Group, L.P. | 125,000 | $634,000 | 0.01% |